Previous close | 0.2000 |
Open | 0.1500 |
Bid | 0.0000 |
Ask | 0.4500 |
Strike | 1.00 |
Expiry date | 2024-11-15 |
Day's range | 0.1500 - 0.2000 |
Contract range | N/A |
Volume | |
Open interest | 90 |
Co-Diagnostics ( NASDAQ:CODX ) First Quarter 2024 Results Key Financial Results Net loss: US$9.31m (loss widened by 62...
Co-Diagnostics, Inc. (NASDAQ:CODX) Q1 2024 Earnings Call Transcript May 9, 2024 Co-Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.31204 EPS, expectations were $-0.21. CODX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the […]
Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Dx," or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter ended March 31, 2024.